ClinicalTrials.gg
CompletedNCT07819617SIPF-RFFFUpdated Sep 15, 2026

Submental Island Flap vs Radial Forearm Free Flap in Tongue Reconstruction

An observational study in Tongue Carcinoma, Tongue Neoplasms and Quality of Life, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Al-Azhar University · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
28
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates and compares the postoperative surgical outcomes and quality of life (QoL) in patients undergoing tongue reconstruction after tongue cancer resection, comparing two reconstructive options: the Submental Island Pedicled Flap (SIPF) and the Radial Forearm Free Flap (RFFF). Quality of life was assessed using the University of Washington Quality of Life questionnaire (UW-QOL v4) to evaluate functional, cosmetic, and psychological recovery.

Read the detailed description

Surgical reconstruction following tongue cancer resection is essential for restoring oral function, speech, swallowing, and facial aesthetics. The Radial Forearm Free Flap (RFFF) is widely considered a gold standard for soft tissue oral reconstruction; however, it requires microvascular expertise and carries donor-site morbidity. The Submental Island Pedicled Flap (SIPF) serves as an alternative, offering a reliable regional pedicled flap with local color match and simplified surgical execution without requiring microvascular anastomoses.

This retrospective observational cohort study aims to compare patients who received SIPF versus RFFF for tongue reconstruction. The primary objective is to evaluate health-related quality of life outcomes using the validated University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), alongside evaluating postoperative surgical outcomes and donor site morbidity.

02

Conditions studied

  • Tongue Carcinoma
  • Tongue Neoplasms
  • Quality of Life

Browse trials for

Keywords

  • Submental flap
  • Radial fore arm flap
  • Quality of life
  • Partial tongue resection
  • Tongue reconstruction
03

In context

Tongue Neoplasms

121 studies on the registry are indexed under Tongue Neoplasms; 12 are open to participants now.

This study's enrollment of 28 is below the median of 97 across 16 observational studies indexed under Tongue Neoplasms.

Browse Tongue Neoplasms studies →

Lead sponsor

Al-Azhar University is the lead sponsor of 531 studies on the registry; 172 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing hemiglossectomy for oral tongue squamous cell carcinoma with immediate reconstruction using either a radial forearm free flap (RFFF) or a submental island pedicled flap (SIPF).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adult patients (aged 18 years or older) diagnosed with squamous cell carcinoma of the tongue requiring partial or total glossectomy.
  2. Indication for immediate soft tissue reconstruction using either Submental Island Pedicled Flap (SIPF) or Radial Forearm Free Flap (RFFF).
  3. Patients eligible and cleared for major surgical resection and flap reconstruction under general anesthesia.
  4. Patient's to participate in the study and complete follow-up evaluations.

Exclusion criteria

Exclusion Criteria:

  1. History of previous radiation therapy or surgical intervention in the head and neck region.
  2. Clinical or radiological evidence of nodal in level I submental lymph nodes (for SIPF candidates).
  3. Severe systemic comorbidities precluding major surgery or prolonged general anesthesia ( IV or higher).
  4. Distance or inability to commit to the 12-month postoperative follow-up schedule and quality of life assessments.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
28 participants (actual)
Patient registry
No

Groups and cohorts

  • SIPF Group

    Patients who underwent tongue reconstruction using Submental Island Pedicled Flap following tongue cancer resection.

    Procedure: Submental Island Pedicled Flap (SIPF)

  • RFFF group

    Patients who underwent tongue reconstruction using Radial Forearm Free Flap following tongue cancer resection.

    Procedure: Radial Forearm Free Flap (RFFF)

Interventions

  • ProcedureSubmental Island Pedicled Flap (SIPF)

    Surgical reconstruction of tongue defect following oncological resection using a pedicled submental island flap.

  • ProcedureRadial Forearm Free Flap (RFFF)

    Surgical reconstruction of tongue defect following oncological resection using a microvascular radial forearm free flap.

06

What researchers measure

Primary outcomes

  1. 12-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)

    Unweighted composite score calculated as the mean of all 12 domains of the University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), evaluated at 12 months postoperatively and adjusted for baseline composite score using analysis of covariance (ANCOVA). Scores range from 0 to 100, where higher scores indicate better quality of life.

    Time frame: 12 months post operatively

Secondary outcomes

  1. 6-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)

    Unweighted composite score of the 12 UW-QOL v4 domains evaluated at 6 months postoperatively and adjusted for baseline composite score using ANCOVA. Scores range from 0 to 100.

    Time frame: 6 months post operatively

  2. Operative time

    Total duration of surgery measured in hours from initial skin incision to final closure.

    Time frame: Day of surgery (intraoperative)

  3. Length of hospital stay

    Total duration of inpatient hospital admission measured in days from surgery until discharge.

    Time frame: From date of surgery to hospital discharge. Up to 30 days

07

Study locations

1 site
  • Faculty of Dental Medicine, Al-Azhar University (Assiut Branch)
    Asyut, Assuit, Egypt
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect patient privacy and confidentiality, in accordance with the institutional ethics review board guidelines.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2024 to primary completion in Apr 2026, 19 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2026
First posted
Sep 15, 2026
StartActual
Sep 1, 2024
Primary completionActual
Apr 1, 2026
CompletionActual
Apr 1, 2026
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07819617
Responsible party
Mohamed Serag Eldin Attia (Principal investigator, Al-Azhar University) — Principal investigator
First posted
Sep 15, 2026
Start date
Sep 1, 2024
Primary completion
Apr 1, 2026
Completion
Apr 1, 2026
Last update
Sep 15, 2026

Study contacts

Mohamed Serag Attia, MSc
principal investigator · Al-Azhar University

Oversight

Data monitoring committee
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion